Research Education Sport Leisure and Travel

Have you got a story or article?

Click Here

Newsletter Subscription

Sign up for E-mail News

Featured Articles

Prostate cancer blood test ‘helps target treatment’ – BBC News

Top healthcare tips for travelling abroad with a disability – Disability Horizons

Bionic hands for children could soon be available on NHS – Daily Mail Online

How to prepare for a PIP assessment – Scope’s Blog

‘Monumental U-turn’ on cancer drug – BBC News

Birmingham Hippodrome to launch new season of Accessible Performances with first ever Relaxed Performance of The Curious Incident of the Dog In The Night Time – DisabledGo News and Blog

Disability and music: WIN disabled singer James Ian’s album Labor of love – Disability Horizons

Accessible taxis: get £15 off your first uberACCESS and uberASSIST ride – Disability Horizons

Theraposture’s new funding guidance for care cots proves popular at Kidz-to-Adultz-South – DisabledGo News and Blog

Care home directors convicted over ‘horrific’ learning disability regime – The Guardian

Assistive apps to help you get around London – Disability Horizons

DPAC protesters march through May’s constituency to highlight austerity impact – DisabledGo News and Blog

Labour pledges ‘transformation’ of social security as it fleshes out disability policies – DisabledGo News and Blog

New TGA Whill Powerchair Generates Inspirational Celebrity Interest at Mobility Roadshow – DisabledGo News and Blog

Honda donates new car to Surf dog who helps disabled kids & veterans

Ataxia

Researchers detected alterations in cerebral brain functions of patients with Friedreich’s ataxia […]

Data from a Phase 2 Friedreich’s ataxia (FA) study by Reata Pharmaceuticals […]

Two new studies of progressive, neurodegenerative diseases linked to defects in cells’ […]

Omaveloxolone, a drug developed by Reata Pharmaceuticals, may slow disease progression and […]

Researchers working in Friedreich’s ataxia may submit their project proposals for funding […]

September 25, is International Ataxia Awareness Day. Chances are you won’t have […]

The selective degeneration of certain neurons in patients with Friedreich’s ataxia may […]

A case report suggests that Friedreich’s ataxia can manifest as abnormal voluntary […]

This report provides comprehensive information on the therapeutic development for Friedreich Ataxia, […]

The Illinois Biotechnology Industry Organization (iBIO) recently announced that Kyle Bryant, founder […]

RaNA Therapeutics, a Cambridge, Massachusetts-based biotech company that develops next-generation RNA-targeted medicines […]

Recently, mutations in transmembrane protein 240 (TMEM240) were identified as the cause […]

Chondrial Therapeutics recently announced that further development of its lead drug candidate […]

Avalanche Biotechnologies, based in Menlo Park, California, is a gene therapy company […]

CAT-4001 is being developed by Catabasis as a potential treatment for neurodegenerative […]